ScholarIQanswers from OpenAlex
AgeneBio (United States)
InstitutionResearch output, impact & collaborations
AgeneBio (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about AgeneBio (United States)?
ScholarIQrecord summary
AgeneBio (United States) is a research organisation in Baltimore, United States. OpenAlex records 13 works and 507 citations for it. 1 researchers list it as their most recent affiliation.
How many works does AgeneBio (United States) have?
ScholarIQindexed works
AgeneBio (United States) has 13 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does AgeneBio (United States) have?
ScholarIQcitation count
AgeneBio (United States) has 507 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at AgeneBio (United States)?
ScholarIQresearcher count
AgeneBio (United States) has 1 researchers in the ScholarIQ index.
What is the average h-index at AgeneBio (United States)?
ScholarIQavg h-index
AgeneBio (United States) has an average h-index of 74 in OpenAlex.
What is the ROR of AgeneBio (United States)?
ScholarIQror
The ROR for AgeneBio (United States) is on the source record.
What is the OpenAlex record for AgeneBio (United States)?
ScholarIQopenalex
The OpenAlex for AgeneBio (United States) is on the source record.
Who are the most-cited researchers behind AgeneBio (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on AgeneBio (United States)?
ScholarIQmost cited works
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs
Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
Richard C. Mohs, David S. Knopman, Ronald C. Petersen, Steven H. Ferris, Chris Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Chris M. Clark, Leon J. Thal
High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging
Lisa Berkman, Teresa E. Seeman, Marilyn Albert, Dan G. Blazer, Robert L. Kahn, Richard C. Mohs, Caleb E. Finch, Edward L. Schneider, Carl W. Cotman, Gerald E. McClearn, John R. Nesselroade, David L. Featherman, Norman Garmezy, Guy M. McKhann, Gilbert Brim, Denis J. Prager, John W. Rowe
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
Richard C. Mohs, David S. Knopman, R. Petersen, Steven H. Ferris, Christopher Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Camilla N. Clark, L. J. Thal
How much of the research on AgeneBio (United States) is open access?
ScholarIQopen access share
50%OPEN ACCESS